Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Dover

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Controlled Clinical Trials|December 1, 1995
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of HydroxyureaS Charache, M L Terrin, R D Moore, et al.
The New England Journal of Medicine|May 18, 1995
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell AnemiaS Charache, M L Terrin, R D Moore, et al.
Blood|June 1, 1984
Fetal hemoglobin synthesis in erythroid cultures in hereditary persistence of fetal hemoglobin and beta o-thalassemiaR S Weinberg, S E Antonarakis, H H Kazazian, et al.
British Journal of Haematology|March 1, 1997
The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for beta S haplotypesY P Chang, M Maier-Redelsperger, K D Smith, et al.
Blood|March 9, 1999
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell diseaseG F Atweh, M Sutton, I Nassif, et al.
Blood|May 25, 1992
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemiaS Charache, G J Dover, R D Moore, et al.
The Journal of Clinical Investigation|May 1, 1985
Alpha thalassemia changes erythrocyte heterogeneity in sickle cell diseaseC T Noguchi, G J Dover, G P Rodgers, et al.
Medicine|November 1, 1996
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell AnemiaS Charache, F B Barton, R D Moore, et al.
Blood|November 1, 1984
Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene clusterS H Boyer, G J Dover, G R Serjeant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemiaS D Gore, L J Weng, S Zhai, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Controlled Clinical Trials|December 1, 1995
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of HydroxyureaS Charache, M L Terrin, R D Moore, et al.
The New England Journal of Medicine|May 18, 1995
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell AnemiaS Charache, M L Terrin, R D Moore, et al.
Blood|June 1, 1984
Fetal hemoglobin synthesis in erythroid cultures in hereditary persistence of fetal hemoglobin and beta o-thalassemiaR S Weinberg, S E Antonarakis, H H Kazazian, et al.
British Journal of Haematology|March 1, 1997
The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for beta S haplotypesY P Chang, M Maier-Redelsperger, K D Smith, et al.
Blood|March 9, 1999
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell diseaseG F Atweh, M Sutton, I Nassif, et al.
Blood|May 25, 1992
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemiaS Charache, G J Dover, R D Moore, et al.
The Journal of Clinical Investigation|May 1, 1985
Alpha thalassemia changes erythrocyte heterogeneity in sickle cell diseaseC T Noguchi, G J Dover, G P Rodgers, et al.
Medicine|November 1, 1996
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell AnemiaS Charache, F B Barton, R D Moore, et al.
Blood|November 1, 1984
Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene clusterS H Boyer, G J Dover, G R Serjeant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemiaS D Gore, L J Weng, S Zhai, et al.
Pageof 8